About 70% of hospital IT pilots fail or face major challenges, according to research from the Standish Group. But it is very rare for hospitals to discuss these setbacks or share studies of implementations that didn’t go as planned.
Two nurse leaders bucked that trend by sharing an…
Source: medcitynews.com – Read more
Novo Nordisk Gets New Complement System Approach to Rare Diseases With Deal for Omeros Drug
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused
